IGC Pharma Inc (IGC)
0.3768
-0.01
(-2.21%)
USD |
NYAM |
Nov 04, 16:00
0.3841
+0.01
(+1.94%)
After-Hours: 20:00
IGC Pharma Shareholders Equity (Quarterly): 7.88M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 7.88M |
March 31, 2024 | 7.321M |
December 31, 2023 | 9.053M |
September 30, 2023 | 14.10M |
June 30, 2023 | 13.20M |
March 31, 2023 | 14.91M |
December 31, 2022 | 18.32M |
September 30, 2022 | 20.14M |
June 30, 2022 | 22.04M |
March 31, 2022 | 23.89M |
December 31, 2021 | 29.48M |
September 30, 2021 | 31.26M |
June 30, 2021 | 31.74M |
March 31, 2021 | 32.80M |
December 31, 2020 | 21.47M |
September 30, 2020 | 23.60M |
June 30, 2020 | 24.86M |
March 31, 2020 | 26.54M |
December 31, 2019 | 29.79M |
September 30, 2019 | 31.24M |
June 30, 2019 | 32.42M |
March 31, 2019 | 33.57M |
December 31, 2018 | 36.56M |
September 30, 2018 | 13.81M |
June 30, 2018 | 7.577M |
Date | Value |
---|---|
March 31, 2018 | 8.065M |
December 31, 2017 | 7.484M |
September 30, 2017 | 6.230M |
June 30, 2017 | 6.104M |
March 31, 2017 | 7.359M |
December 31, 2016 | 7.549M |
September 30, 2016 | 14.40M |
June 30, 2016 | 13.10M |
March 31, 2016 | 13.48M |
December 31, 2015 | 13.09M |
September 30, 2015 | 13.57M |
June 30, 2015 | 13.98M |
March 31, 2015 | 14.23M |
December 31, 2014 | 15.74M |
September 30, 2014 | 15.36M |
June 30, 2014 | 16.25M |
March 31, 2014 | 13.63M |
December 31, 2013 | 13.75M |
September 30, 2013 | 13.93M |
June 30, 2013 | 13.92M |
March 31, 2013 | 14.44M |
December 31, 2012 | 14.56M |
September 30, 2012 | 14.24M |
June 30, 2012 | 14.46M |
March 31, 2012 | 14.84M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
7.321M
Minimum
Mar 2024
32.80M
Maximum
Mar 2021
21.18M
Average
22.04M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 8.473M |
AIM ImmunoTech Inc | 6.102M |
NovaBay Pharmaceuticals Inc | -0.617M |
Protalix BioTherapeutics Inc | 28.58M |
Palatin Technologies Inc | -0.1115M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 10.59M |
Total Liabilities (Quarterly) | 2.714M |
Debt to Equity Ratio | 0.0173 |
Current Ratio | 1.771 |
Net Debt Paydown Yield | 0.00% |